Reporting options
Amyloid tracer reporting and regions of interest.
AI Neurology & Neuro-Oncology
NeuroQuant® PET
Automated amyloid PET analysis for clear, standardized insights.
NeuroQuant® PET
Rapid, Automated Amyloid PET Quantification and Centiloid Scoring
NeuroQuant® PET provides fully automated amyloid PET quantification, combining regional analysis and Centiloid scoring to support the interpretation of established biomarkers.
FDA 510(k) CLEARED (K261916)
Clearer Insights into Lesion Changes
Amyloid Quantification
Standardized Amyloid Reporting and Centiloid Quantification to Support Established Biomarker Interpretation
Support clinical assessment with objective volumetric data and color-coded brain structure images to inform diagnosis, treatment, and lifestyle planning. Assess lesion dissemination and distribution patterns, identify areas with the greatest lesion burden, and track lesions across orthogonal views.
NeuroQuant® PET Benefits
Smarter PET Analysis
Clear visualization
Fusion images and anatomical overlays.
Automated processing
Automated cloud-based processing.
Reports
NeuroQuant® PET
Powered by NeuroQuant® for trusted, proven brain segmentation and analysis.
Florbetapir Report
The NeuroQuant® PET Florbetapir Report automatically quantifies amyloid tracer binding within brain structures, providing visual and statistical comparisons of normalized regional PET tracer values against normative population data. The report also includes a Centiloid value.
Florbetaben Report
The NeuroQuant® PET Florbetaben Report automatically quantifies amyloid tracer binding within brain structures, providing visual and statistical comparisons of normalized regional PET tracer values against normative population data. The report also includes a Centiloid value.
Flutemetamol Report
The NeuroQuant® PET Flutemetamol Report automatically quantifies amyloid tracer binding within brain structures, providing visual and statistical comparisons of normalized regional PET tracer values against normative population data. The report also includes a Centiloid value.
NeuroQuant® PET
Research Applications
Explore additional NeuroQuant® PET outputs for regional quantification and comparison in research studies.
FDG Report
Provides regional quantification of glucose metabolism.
Flortaucipir (Tau) Report
Quantifies tau tracer uptake across brain regions.
Z-Score Reporting
Compares regional values against normative population data.
Research Reports
NeuroQuant® PET
Powered by NeuroQuant® for trusted, proven brain segmentation and analysis.
FDG Report
The NeuroQuant® PET FDG Report automatically quantifies metabolic tracer uptake within brain structures, providing visual and statistical comparisons of normalized regional PET tracer values against normative population data.
Florbetaben Report
The NeuroQuant® PET Flortaucipir Report automatically quantifies tau tracer uptake within brain structures, providing visual and statistical comparisons of normalized regional PET tracer values against normative population data.
Flortaucipir measures tau rather than amyloid, so the Centiloid reference has been removed.
Take the next step
NeuroQuant® PET
Clearer insights into
amyloid PET imaging.
Discover how NeuroQuant® PET supports amyloid PET interpretation with automated regional quantification and Centiloid scoring. Speak with ARJ Medical for product information or a demonstration.
Request a demoLet’s discuss your amyloid PET imaging workflow.
